Sequence rearrangements and genome instability. A possible step in carcinogenesis

Insights

Non-coding DNA sequences are vulnerable to DNA-damaging agents, potentially driving cancer by causing genomic instability and chromosomal rearrangements. These changes in the genome may be as critical as gene mutations in malignant transformation.

Area of Science:

  • Genomics
  • Molecular Biology
  • Cancer Research

Background:

  • A significant portion of the mammalian genome lacks structural genes, making it a potential target for DNA-damaging agents.
  • These non-coding sequences may play a crucial role in carcinogenesis by promoting genomic instability.
  • DNA-damaging agents can induce recombination-prone sites, leading to chromosomal lesions and gene rearrangements.

Purpose of the Study:

  • To investigate the role of non-coding DNA sequences as targets for DNA-damaging agents.
  • To explore the involvement of these sequences in genomic instability and carcinogenesis.
  • To understand the significance of chromosomal rearrangements in malignant transformation.

Main Methods:

  • Analysis of DNA-damaging agents' effects on non-coding genomic regions.
  • Investigation of chromosomal lesions and gene rearrangements in malignancy.
  • Comparative analysis of sequence rearrangements across different organisms.

Main Results:

  • Non-coding DNA sequences are susceptible to DNA-damaging agents, contributing to genome instability.
  • These agents induce recombination-prone sites, resulting in extensive chromosomal damage.
  • Extensive chromosomal rearrangements are a hallmark of malignancy in humans and animals.

Conclusions:

  • Damage to non-coding DNA and subsequent sequence shuffling are critical factors in malignant transformation.
  • The role of movable sequences in higher animals warrants further investigation.
  • Genomic instability driven by damage to non-coding DNA is as important as point mutations in cancer development.

Related Concept Videos

Mismatch Repair01:36

Mismatch Repair

Overview
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Spontaneous and Induced Mutations01:30

Spontaneous and Induced Mutations

Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).